Skip to main content

Orchard Therapeutics plc

ORTXDelisted Jan 24, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001748907

Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in Orchard Therapeutics plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
−2 vs. Q2 2022
Shares held
49.4M
−2.39M (−4.6%) vs. Q2 2022
Total value
$24.7M
−$5.55M (−18.4%) vs. Q2 2022
New holders
8
9 more added
Sold out
10
12 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ORTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 47 institutions
Q1 2021: 83 institutionsQ2 2021: 85 institutionsQ3 2021: 79 institutionsQ4 2021: 72 institutionsQ1 2022: 61 institutionsQ2 2022: 50 institutionsQ3 2022: 47 institutionsQ4 2022: 47 institutionsQ1 2023: 35 institutionsQ2 2023: 33 institutionsQ3 2023: 32 institutionsQ4 2023: 47 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $24.7M
Q1 2021: $546.3MQ2 2021: $350.8MQ3 2021: $167.4MQ4 2021: $84.6MQ1 2022: $38.9MQ2 2022: $30.2MQ3 2022: $24.7MQ4 2022: $16.3MQ1 2023: $31.2MQ2 2023: $26.2MQ3 2023: $46.9MQ4 2023: $122.0MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ORTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202347$122.0M
Q3 202332$46.9M
Q2 202333$26.2M
Q1 202335$31.2M
Q4 202247$16.3M
Q3 202247$24.7M
Q2 202250$30.2M
Q1 202261$38.9M
Q4 202172$84.6M
Q3 202179$167.4M
Q2 202185$350.8M
Q1 202183$546.3M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Orchard Therapeutics plc; share changes are against Q2 2022.

Institutions holding ORTX in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC8,611,375$4.31M0.00%00.0%Unchanged
Federated Hermes, Inc.8,401,687$4.20M0.01%+91,828+1.1%Added
CHI Advisors LLC7,987,396$3.99M1.07%+2,679,645+50.5%Added
Deerfield Management Company, L.P. (Series C)6,949,416$3.48M0.07%00.0%Unchanged
Temasek Holdings (Private) Ltd4,319,049$2.16M0.01%00.0%Unchanged
Renaissance Technologies LLC2,535,439$1.27M0.00%+549,151+27.6%Added
Citadel Advisors LLC2,290,342$1.15M0.00%+2,268,933+10,598.0%Added
Tang Capital Management LLC2,000,000$1.00M0.12%00.0%Unchanged
Artal Group S.A.1,803,858$902.0K0.05%00.0%Unchanged
Acadian Asset Management LLC1,098,594$549.0K0.00%+836,911+319.8%Added
BlackRock Inc.712,001$356.0K0.00%−21,546−2.9%Reduced
Strategic Wealth Advisors Group, LLC516,975$258.0K0.01%+516,975New
UBS Oconnor LLC432,978$216.0K0.00%−660,946−60.4%Reduced
Millennium Management LLC358,869$179.0K0.00%+177,410+97.8%Added
Morgan Stanley297,480$149.0K0.00%−65,073−17.9%Reduced
Cormorant Asset Management, LP256,649$128.0K0.01%00.0%Unchanged
JPMorgan Chase & Co222,549$111.0K0.00%−1,374,062−86.1%Reduced
Forefront Analytics, LLC100,041$54.0K0.03%+7,400+8.0%Added
Bank of America Corp71,503$36.0K0.00%−14,552−16.9%Reduced
Verition Fund Management LLC50,000$25.0K0.00%00.0%Unchanged
Jane Street Group, LLC45,953$23.0K0.00%+45,953New
Two Sigma Investments, LP36,591$18.0K0.00%+16,556+82.6%Added
Balyasny Asset Management LLC33,717$17.0K0.00%+33,717New
Geode Capital Management, LLC26,079$13.0K0.00%00.0%Unchanged
Banque Cantonale Vaudoise24,000$12.0K0.00%00.0%Unchanged
Spears Abacus Advisors LLC21,145$11.0K0.00%−1,230−5.5%Reduced
Two Sigma Advisers, LP19,500$10.0K0.00%+19,500New
Allegheny Financial Group LTD16,750$8.00K0.00%+16,750New
IPG Investment Advisors LLC14,100$7.05K0.00%00.0%Unchanged
Wells Fargo & Company12,500$7.00K0.00%00.0%Unchanged
Holderness Investments Co14,730$7.00K0.00%+14,730New
Two Sigma Securities, LLC13,825$7.00K0.00%+13,825New
Oppenheimer & Co Inc11,700$6.00K0.00%−2,400−17.0%Reduced
HighTower Advisors, LLC12,000$6.00K0.00%00.0%Unchanged
Ironsides Asset Advisors, LLC10,651$5.00K0.00%00.0%Unchanged
Connecticut Wealth Management, LLC10,000$5.00K0.00%00.0%Unchanged
Running Point Capital Advisors, LLC10,000$5.00K0.00%−703−6.6%Reduced
American Portfolios Advisors6,375$3.19K0.00%00.0%Unchanged
UBS Group AG3,809$2.00K0.00%−53−1.4%Reduced
Citigroup Inc1,181$1.00K0.00%−49,550−97.7%Reduced
Barclays PLC2,000$1.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,979$1.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)753$00.00%−6,467−89.6%Reduced
Royal Bank of Canada9$00.00%−2,000−99.6%Reduced
Simplex Trading, LLC1,870$00.00%+1,000+114.9%Added
Mine & Arao Wealth Creation & Management, LLC.100$00.00%00.0%Unchanged
Beaird Harris Wealth Management, LLC120$00.00%+120New
Artisan Partners Limited Partnership0$00.00%−3,322,737−100.0%Sold out
Ra Capital Management, L.P.0$00.00%−3,040,885−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−616,402−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−226,271−100.0%Sold out
New York State Common Retirement Fund0$00.00%−115,006−100.0%Sold out
State Street Corp0$00.00%−110,366−100.0%Sold out
SEI Investments Co0$00.00%−34,151−100.0%Sold out
Lane Generational LLC0$00.00%−10,828−100.0%Sold out
Concord Wealth Partners0$00.00%−1,000−100.0%Sold out
Captrust Financial Advisors0$00.00%−750−100.0%Sold out
Altium Wealth Management LLC––––Not filed